Published in Eur Heart J on March 21, 2010
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis. Circ Cardiovasc Imaging (2015) 1.46
Current management of calcific aortic stenosis. Circ Res (2013) 1.18
Grading aortic stenosis severity when the flow modifies the gradientvalve area correlation. Cardiovasc Diagn Ther (2012) 0.87
Exercise echocardiography in aortic stenosis: one more piece in the puzzle. Eur Heart J (2010) 0.82
Calcific aortic stenosis. Nat Rev Dis Prim (2016) 0.79
Echocardiography in the era of multimodality cardiovascular imaging. Biomed Res Int (2013) 0.79
Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise. Cardiovasc Ultrasound (2013) 0.79
Assessment of Aortic Valve Disease: Role of Imaging Modalities. Curr Treat Options Cardiovasc Med (2015) 0.76
Exercise stress echocardiography in patients with valvular heart disease. Echo Res Pract (2015) 0.76
Exercise stress echocardiography with tissue Doppler imaging in risk stratification of mild to moderate aortic stenosis. Int J Cardiovasc Imaging (2015) 0.76
The Role of Imaging in Aortic Valve Disease. Curr Cardiovasc Imaging Rep (2016) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Advanced imaging in valvular heart disease. Nat Rev Cardiol (2017) 0.75
Patient selection for transcatheter aortic valve replacement: A combined clinical and multimodality imaging approach. World J Cardiol (2017) 0.75
How to relate diastolic left ventricular dysfunction to the results of stress echocardiography in aortic stenosis? Cardiovasc Diagn Ther (2013) 0.75
Prognostic Value of Aortic Valve Area by Doppler Echocardiography in Patients With Severe Asymptomatic Aortic Stenosis. J Am Heart Assoc (2016) 0.75
Exercise echocardiography in asymptomatic patients with severe aortic stenosis and preserved left ventricular ejection fraction. J Cardiovasc Ultrasound (2014) 0.75
Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2013) 0.75
Assessment of aortic valve disease - a clinician oriented review. World J Cardiol (2017) 0.75
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med (2008) 10.03
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34
Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med (2000) 4.13
Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation (1997) 3.72
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14
Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation (2005) 2.20
Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J (2004) 2.11
Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart (2001) 2.07
Exercise testing to stratify risk in aortic stenosis. Eur Heart J (2005) 1.97
Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg (2006) 1.84
Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation (2009) 1.76
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation (2004) 1.56
Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation (2004) 1.39
Aortic valve calcification: determinants and progression in the population. Arterioscler Thromb Vasc Biol (2006) 1.38
The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol (2009) 1.23
Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation (2005) 1.21
Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study. Circulation (2008) 1.11
Flow dependence of measures of aortic stenosis severity during exercise. J Am Coll Cardiol (1994) 0.99
Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol (2005) 0.98
Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J Am Coll Cardiol (1992) 0.92
Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. J Heart Valve Dis (2002) 0.91
Left ventricular response to exercise in aortic stenosis: an exercise echocardiographic study. Echocardiography (2007) 0.90
Rapid progression of mild to moderate aortic stenosis in patients older than 80 years. J Am Soc Echocardiogr (2007) 0.87
Exercise testing and exercise stress echocardiography in asymptomatic aortic valve stenosis. Heart (2008) 0.87
Determinants of an abnormal response to exercise in patients with asymptomatic valvular aortic stenosis. Eur J Echocardiogr (2007) 0.83
Does exercise echocardiography have an added value over exercise testing alone in asymptomatic patients with severe aortic stenosis? J Heart Valve Dis (2008) 0.80
Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med (2003) 5.33
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol (2008) 5.19
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology (2004) 3.50
Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol (2009) 3.49
Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol (2008) 3.32
Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation (2007) 3.24
Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol (2012) 3.15
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol (2003) 3.02
Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol (2011) 2.83
Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol (2008) 2.58
Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation (2009) 2.40
The infective endocarditis team: recommendations from an international working group. Heart (2013) 2.39
Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol (2005) 2.33
Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol (2005) 2.31
Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation (2006) 2.29
Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation (2010) 2.13
In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg (2007) 2.13
Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J (2007) 2.12
Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitation. J Heart Valve Dis (2012) 2.08
Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology (2008) 2.07
Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation (2003) 2.06
Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol (2009) 2.05
Pivotal role of bedside Doppler echocardiography in the assessment of patients with acute heart failure and mitral regurgitation. Cardiology (2009) 2.03
Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol (2011) 2.02
Comparison of peak flow velocity through the left ventricular outflow tract and effective orifice area indexed to body surface area in Golden Retriever puppies to predict development of subaortic stenosis in adult dogs. J Am Vet Med Assoc (2014) 2.00
Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension (2009) 2.00
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur Heart J (2011) 1.93
Discrepancies between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon: practical implications with regard to quantification of aortic stenosis severity. J Am Coll Cardiol (2003) 1.89
The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J (2012) 1.88
Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation (2006) 1.86
Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J (2004) 1.82
Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol (2010) 1.81
Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J (2009) 1.81
Speckle tracking analysis allows sensitive detection of stress cardiomyopathy in severe aneurysmal subarachnoid hemorrhage patients. Intensive Care Med (2016) 1.80
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol (2013) 1.79
Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation (2007) 1.78
Prosthesis-patient mismatch: an update. Curr Cardiol Rep (2011) 1.77
Direct comparison of whole-heart navigator-gated magnetic resonance coronary angiography and 40- and 64-slice multidetector row computed tomography to detect the coronary artery stenosis in patients scheduled for conventional coronary angiography. Circ Cardiovasc Imaging (2008) 1.77
Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol (2008) 1.71
Continued global left ventricular remodeling is not the sole mechanism responsible for the late recurrence of ischemic mitral regurgitation after restrictive annuloplasty. J Am Soc Echocardiogr (2009) 1.63
Impact of anesthesia on echocardiographic evaluation of systolic and diastolic function in rats. J Am Soc Echocardiogr (2006) 1.63
Ross operation in the adult: long-term outcomes after root replacement and inclusion techniques. Ann Thorac Surg (2009) 1.62
Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv (2012) 1.60
Valve prosthesis-patient mismatch, 1978 to 2011: from original concept to compelling evidence. J Am Coll Cardiol (2012) 1.60
Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging (2011) 1.59
Visceral obesity and the heart. Int J Biochem Cell Biol (2007) 1.58
Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J (2009) 1.57
Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation (2006) 1.55
Relationship between transmural extent of necrosis and quantitative recovery of regional strains after revascularization. JACC Cardiovasc Imaging (2010) 1.54
Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. Eur Heart J (2008) 1.53
Flow-dependent changes in Doppler-derived aortic valve effective orifice area are real and not due to artifact. J Am Coll Cardiol (2005) 1.53
Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol (2012) 1.52
Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J (2005) 1.52
Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis (2010) 1.52
Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol (2008) 1.51
Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. J Am Coll Cardiol (2012) 1.50
Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J (2009) 1.49
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv (2013) 1.48
Prognostic value of plasma B-type natriuretic peptide levels after exercise in patients with severe asymptomatic aortic stenosis. Heart (2014) 1.47
Association of Bicuspid aortic valve morphology and aortic root dimensions: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. Echocardiography (2009) 1.46
Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis (2008) 1.46
Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor. J Thorac Cardiovasc Surg (2006) 1.46
Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann Thorac Surg (2008) 1.45
Mid-ventricular ballooning heart syndrome. Echocardiography (2007) 1.45
Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. JACC Cardiovasc Imaging (2011) 1.44
Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women. Am J Med (2003) 1.44
Manufacturer-provided effective orifice area index charts and the prevention of prosthesis-patient mismatch. J Heart Valve Dis (2012) 1.44
Chordal cutting technique through aortotomy: a new approach to treat chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2005) 1.43
Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation (2007) 1.42
The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med (2006) 1.42
Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance. EuroIntervention (2015) 1.41
Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: a multicenter analysis. Circ Cardiovasc Imaging (2013) 1.41
Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol (2003) 1.40
The approach does not disqualify prosthesis-patient mismatch. Eur J Cardiothorac Surg (2002) 1.40